Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06616753

Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital

The goal of this observational study is to learn about the rate of knowledge of own vaccination status among patients hospitalized at Melun hospital. The main questions it aims to answer are:

* the rate of knowledge of its vaccination status among patients hospitalized at Melun hospital * hospitalized patients' attitude to vaccination in general. Evaluate the number of patients wishing to update their vaccination status. Observe the influence of various factors (gender, occupation, presence or absence of GP, chronic illness) on vaccination status in Melun, France Participants will be asked to complete a questionnaire during hospitalization.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Vaccinia DNA Virus Infections Infections Poxviridae Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

As part of the national "European Vaccination Week" event organized by the French Ministry of Health and Prevention, we are asking a sample of patients hospitalized in our hospital to complete a questionnaire on their knowledge of their vaccination status, and to assess their relationship with vaccination.

Questionnaire administered to patient during hospitalization (n=140 patients). Patients randomly selected by the Department of Medical Information of the hospital at the beginning of the survey week.

Patients randomly selected from each of the 10 departments of the CH of Melun (internal medicine, infectious diseases, gastroenterology, pneumology, surgery, BCR medicine, cardiology, nephrology, follow-up care and rehabilitation and geriatrics) and accompanied to complete a questionnaire set up by the Public Health Unit (USP) and Hygiene Operational Team (EOH) of the CH of Melun.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • French-speaking and non-demented patient : able to speak and understand French and without dementia
  • Adult patient (Age ≥ 18 years)
  • Main place of residence in France
  • Hospitalized in a department of the CH of Melun

Exclusion criteria

  • Does not speak French or dementia
  • Patient's refusal to participate in the study

Treatment and study plan

vaccination status

Biological

knowledge of own vaccination status

Primary outcomes

  1. Evaluate the rate of knowledge of own vaccination status

    Time frame: Day 1

Secondary outcomes

  1. Evaluate the number of patients wishing to update their vaccination status

    Time frame: Day 1

  2. 3.Observe the influence of various factors in vaccination status at Melun Hospital : 3.1 % of each gender 3.2 % of patients with a specefic occupation 3.3 % of patients with or without a treating physician 3.4 Rate of patients with chronic illness

    Time frame: Day 1

Study contacts

Contact information is provided by the study sponsor or research team.

AGHER AREZKI

CONTACT

[email protected]

0033181742228

CORALIE NOEL

CONTACT

[email protected]

0033181742127

Sponsors and collaborators

Lead sponsor

Groupe Hospitalier Sud Ile-de-France

Other

Registry information

Official study title

Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital : Observational Trial

Acronym: StatutvaxPat

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Sep 27, 2024
Registry last updated
Jun 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.